Estrella Immunopharma Statistics
NASDAQ: ESLAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4175-0.0018 (-0.43%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Estrella Immunopharma by the numbers
Estrella Immunopharma has a market capitalization of $18.2 million based on 43.50M shares outstanding. With trailing EPS of $-0.25, Estrella Immunopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 34.2% below its 50-day average and 60.5% below its 200-day average.
Average daily trading volume is 38.27K shares, or about $15,978 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ESLA valuation vs. peer median
| Metric | ESLA | Peer median | Difference |
|---|---|---|---|
| Market cap | $18.16M | $15.76M | +15% |
| Avg. volume | 38.27K | 130.80K | -71% |
Peer median across 8 companies: JSPR, DYAI, BCDA, SCLX, TCRX, INAB, PLUR, PASG.
Valuation
- Market cap
- $18.16M
- EPS (TTM)
- $-0.25
- Shares outstanding
- 43.50M
Price and trading
- Previous close
- 0.4193
- Open
- 0.41
- Day range
- 0.3611 – 0.426
- 52-week range
- 0.3611 – 3.15
- 52-week change
- -67.88%
- 50-day moving average
- 0.6346
- Beta
- —
- Volume
- 72.03K
- Average volume
- 38.27K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 18.16M
- Forward Pe
- -1.30
- Eps
- -0.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.15
- Week52 Low
- 0.36
- Avg Volume
- 38,270.00
- Shares Outstanding
- 43.50M
- Ma50
- 0.63
- Ma200
- 1.06
- Pct From52w High
- -86.75%
- Pct From52w Low
- 15.62%